Simulations Plus, Inc. (AMEX: SLP) announces that Walt Woltosz, chairman and CEO, will be live on Market News First (mn1.com) for an exclusive interview with the MN1 radio team. The interview is set for Wednesday, August 9, 2006, at 2:00 p.m. EDT.
Simulations Plus is a leading developer of simulation and modeling software for pharmaceutical discovery and development, and a leading consulting firm to the industry in the areas of oral drug absorption and pharmacokinetics. The company’s software addresses three critical needs in pharmaceutical R&D: (1) Predicting the properties of new potential drug molecules from their structure, (2) analyzing high throughput screening data to find common molecular structural characteristics associated with measured properties, and (3) simulating how drugs are dissolved, absorbed, and distributed into different tissues in humans and in animals. These tools enable researchers to avoid unnecessary experiments in the lab and in animals, and they provide a means for understanding complex experimental results. The Company’s software products and consulting services are used by about 60 companies in the U.S., Europe, and Japan.
To learn more about Simulations Plus, log on to MN1.com and join company CEO Walt Woltosz as he talks about the company’s goals.